Encapsulation of Beauveria bassiana conidia as a new strategy for the biological control of Aedes aegypti larvae.

The virulence of encapsulated fungal conidia against Aedes aegypti larvae was investigated. Molecular studies confirmed that the fungal isolate used here was Beauveria bassiana. Different conidial concentrations were tested. A concentration of 1 × 10 conidia mL was the most effective, resulting in 7% larval survival after 7 days. Next, alginate capsules (0.65%) containing conidia were prepared with different densities of calcium chloride (0.01 M, 0.009 M, and 0.008 M CaCl₂) and tested against larvae. Furthermore, groups of capsules were prepared with bird diet to act as an attractant. All capsule densities tested reduced larval survival (ranging from 22 to 67%). However, capsules with 0.008 M CaCl₂ were the most effective. Furthermore, fungus-only capsules were more efficient when compared to those containing bird diet. Laboratory and semi-field bioassays were conducted using mixtures of capsules with different densities. In the laboratory, survival ranged from 26 to 53%, whereas in semi-field conditions, 35%, and 80% survival was observed for groups exposed to fungus-only capsules or capsules containing diet, respectively. Histopathological studies of larvae exposed to capsules showed the presence of the fungus in the digestive tract and visible damage to enterocytes. These findings offer new insights into the biological control of Ae. aegypti larvae.